Prostaglandin Inhibition for Emphysema

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Emphysema
Interventions
DRUG

600 mg ibuprofen three times daily for 48 weeks

OTHER

Placebo three times daily

Trial Locations (5)

19140

Temple University, Philadelphia

35233

University of Alabama at Birmingham, Birmingham

68105

Univerisity of Nebraska Medical Center, Omaha

80206

National Jewish Health, Denver

90502

Harbor-UCLA Medical Center, Torrance

All Listed Sponsors
collaborator

National Jewish Health

OTHER

collaborator

Temple University

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

University of Nebraska

OTHER

NCT02006576 - Prostaglandin Inhibition for Emphysema | Biotech Hunter | Biotech Hunter